tirzepatide for obesity fda approval approves weight-loss drug Zepbound to treat sleep apnea GLP-1 Medications for Weight Loss:

This program marks a significant shift in Medicare policy, as traditional Part D plans have not covered drugs primarily for weight management

if pancreatitis is confirmed, do not resume semaglutide

According to the Lilly statement, this discovery is concerning because nothing is known about the short- or long-term effects of this molecule in humans, or whether there are any potential impacts on the drugs efficacy, toxicity, or immune reactions

Skeletal muscle insulin resistance: role of mitochondria and other ROS sources

Administered via a once-weekly injection, semaglutide offers convenience and flexibility for patients, allowing them to integrate the treatment into their lifestyle while working towards their health goals